Tampa

The trials here

What the 10 trials at this site are about, from their registry records.

Conditions

• Alzheimer disease3 trials
• Fibromyalgia2 trials
• Hidradenitis suppurativa2 trials
• Depression1 trial
• Narcolepsy1 trial

Phase

• Phase 38 trials
• Phase 22 trials

Status

• Completed4 trials
• Recruiting3 trials
• Terminated2 trials
• Enrolling by invitation1 trial

Lead sponsor

• Axsome Therapeutics, Inc.7 trials
• ACELYRIN Inc.2 trials
• Tonix Pharmaceuticals, Inc.1 trial

Running trials

• Recruiting

  Studying NMDA and Sigma-1 in Smoking Cessation Treatment (SUMMIT)

  NCT07766655· Phase 3· Axsome Therapeutics, Inc.· Source

  Contact: Study Director

• Recruiting

  A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)

  NCT07621237· Phase 2· Tonix Pharmaceuticals, Inc.· Source

  Contact: Timothy Roush

• Enrolling by invitation

  Open-Label Safety Study of AXS-14 in Subjects With Fibromyalgia

  NCT07637162· Phase 3· Axsome Therapeutics, Inc.· Source

• Recruiting

  Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design

  NCT07398417· Phase 3· Axsome Therapeutics, Inc.· Source

  Contact: Study Director

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Fibromyalgia2 recruiting
• Depression1 recruiting

Closed trials

• Terminated

  An Open-Label Study to Assess the Long-term Safety of AXS-05 in Subjects With Dementia of the Alzheimer's Type, ADVANCE-2 and ACCORD-2 Extension Study

  NCT06736509· Phase 3· Axsome Therapeutics, Inc.· Source

• Terminated

  Hidradenitis Suppurativa Study of Izokibep

  NCT05905783· Phase 3· ACELYRIN Inc.· Source

• Completed

  A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation

  NCT05557409· Phase 3· Axsome Therapeutics, Inc.· Source

• Completed

  Hidradenitis Suppurativa Phase 2b Study of Izokibep

  NCT05355805· Phase 2· ACELYRIN Inc.· Source

• Completed

  A Study to Assess the Efficacy and Safety of AXS-12 (Reboxetine) in Patients With Narcolepsy

  NCT05059223· Phase 3· Axsome Therapeutics, Inc.· Source

• Completed

  A Study to Assess the Long-term Safety and Efficacy of AXS-05 in Subjects With Alzheimer's Disease Agitation

  NCT04947553· Phase 3· Axsome Therapeutics, Inc.· Source